[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424.
|
[2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66: 115-132.
|
[3] |
Lu TX, Rothenberg ME. MicroRNA[J]. J Allergy Clin Immunol, 2018, 141: 1202-1207.
|
[4] |
Wang Z. The guideline of the design and validation of miRNA mimics[J]. Methods Mol Biol, 2011, 676: 211-223.
|
[5] |
Huang GL, Sun J, Lu Y, et al. miR-200 family and cancer: from a meta-analysis view[J]. Mol Aspects Med, 2019, 70: 57-71.
|
[6] |
武坤, 聂波, 李云涛, 等. 外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用[J]. 基础医学与临床, 2022, 42: 871-875.
|
[7] |
Sengupta D, Deb M, Kar S, et al. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention[J]. Semin Cancer Biol, 2021, 72: 46-64.
|
[8] |
Paterson EL, Kazenwadel J, Bert AG, et al. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression[J]. Neoplasia, 2013, 15: 180-191.
|
[9] |
Karin N, Razon H. Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoim-munity[J]. Cytokine, 2018, 109: 24-28.
|
[10] |
Khorasani M, Shahbazi S, Hosseinkhan N, et al. Analysis of differential expression of microRNAs and their target genes in prostate cancer: a bioinformatics study on microarray gene expression data[J]. Int J Mol Cell Med, 2019, 8: 103-114.
|
[11] |
Liu L, Zhou Z, Huang S, et al. Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells[J]. Biochem J, 2013, 451: 55-60.
|
[12] |
Leick KM, Rodriguez AB, Melssen MM, et al. The barrier molecules junction plakoglobin, filaggrin, and dystonin play roles in melanoma growth and angiogenesis[J]. Ann Surg, 2019, 270: 712-722.
|